Suppr超能文献

益生菌如何影响微生物组。

How Probiotics Affect the Microbiota.

机构信息

Service de Médecine Interne Générale, Clinique Saint Pierre, Ottignies, Belgium.

Service de Médecine Interne et Maladies Infectieuses, Cliniques Universitaires Saint Luc, UCLouvain, Université Catholique de Louvain, Brussels, Belgium.

出版信息

Front Cell Infect Microbiol. 2020 Jan 15;9:454. doi: 10.3389/fcimb.2019.00454. eCollection 2019.

Abstract

Probiotics have been used to treat a variety of diseases for decades; however, what is the rationale for their application? Such a treatment was first proposed in the early nineteenth century based on observations of decreased bifidobacterial populations in children suffering from diarrhea, suggesting that oral intake of bifidobacteria could replete this subpopulation of the microbiota and improve health. Since then, studies have shown modifications in the gut or skin microbiota in the course of a variety of diseases and suggested positive effects of certain probiotics. Most studies failed to report any impact on the microbiota. The impact of probiotics as well as of bacteria colonizing food does not reside in their ability to graft in the microbiota but rather in sharing genes and metabolites, supporting challenged microbiota, and directly influencing epithelial and immune cells. Such observations argue that probiotics could be associated with conventional drugs for insulin resistance, infectious diseases, inflammatory diseases, and psychiatric disorders and could also interfere with drug metabolism. Nevertheless, in the context of a plethora of probiotic strains and associations produced in conditions that do not allow direct comparisons, it remains difficult to know whether a patient would benefit from taking a particular probiotic. In other words, although several mechanisms are observed when studying a single probiotic strain, not all individual strains are expected to share the same effects. To clarify the role of probiotics in the clinic, we explored the relation between probiotics and the gut and skin microbiota.

摘要

益生菌已被用于治疗各种疾病数十年;然而,它们应用的原理是什么?这种治疗方法最初是在 19 世纪初提出的,其依据是观察到患有腹泻的儿童双歧杆菌种群减少,这表明口服双歧杆菌可以补充这种微生物群的亚群并改善健康。从那时起,研究表明在各种疾病过程中肠道或皮肤微生物群发生了变化,并表明某些益生菌具有积极作用。大多数研究未能报告对微生物群有任何影响。益生菌以及定植于食物中的细菌的影响不在于它们在微生物群中定植的能力,而在于它们共享基因和代谢物,支持受到挑战的微生物群,并直接影响上皮细胞和免疫细胞。这些观察结果表明,益生菌可能与治疗胰岛素抵抗、传染病、炎症性疾病和精神疾病的常规药物相关联,并且还可能干扰药物代谢。然而,在存在大量益生菌株和在不允许直接比较的条件下产生的关联的情况下,仍然很难知道患者是否会从服用特定益生菌中受益。换句话说,尽管在研究单一益生菌株时观察到几种机制,但并非所有个体菌株都预计会具有相同的作用。为了阐明益生菌在临床上的作用,我们探讨了益生菌与肠道和皮肤微生物群之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af33/6974441/4a684267e151/fcimb-09-00454-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验